Zhejiang Realsun Chemical Co.,Ltd. (SHE:301212)
China · Delayed Price · Currency is CNY 32.29
-0.38 (-1.16%)
At close: Feb 27, 2026
Zhejiang Realsun Chemical Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 |
Operating Revenue | 709.86 | 632.46 | 662.02 | 1,041 | 831.01 | 673.23 |
Other Revenue | - | - | - | - | 2.01 | 6.5 |
| 709.86 | 632.46 | 662.02 | 1,041 | 833.01 | 679.73 | |
Revenue Growth (YoY) | 23.59% | -4.46% | -36.41% | 24.98% | 22.55% | 21.69% |
Cost of Revenue | 637.25 | 570.63 | 540.47 | 789.66 | 653.47 | 485.17 |
Gross Profit | 72.6 | 61.83 | 121.54 | 251.47 | 179.54 | 194.56 |
Selling, General & Admin | 38.87 | 35.88 | 41.6 | 40.98 | 36.31 | 37.37 |
Research & Development | 21.88 | 20.39 | 25.57 | 32.94 | 26.24 | 22.56 |
Other Operating Expenses | 1.96 | 1.34 | 1.75 | 4.51 | 3.05 | 4.18 |
Operating Expenses | 63.22 | 60.18 | 65.07 | 78.47 | 66.23 | 63.23 |
Operating Income | 9.39 | 1.64 | 56.47 | 173 | 113.31 | 131.33 |
Interest Expense | -0.07 | -0.08 | -0.22 | -1.94 | -1.81 | -2.36 |
Interest & Investment Income | 7.74 | 12.78 | 19.86 | 15.87 | 0.24 | 2.81 |
Currency Exchange Gain (Loss) | 2.75 | 2.75 | 3.57 | 32.17 | -5.35 | -9.06 |
Other Non Operating Income (Expenses) | -1.5 | -0.31 | -0.23 | -0.6 | -0.59 | -0.65 |
EBT Excluding Unusual Items | 18.3 | 16.79 | 79.45 | 218.5 | 105.8 | 122.08 |
Gain (Loss) on Sale of Investments | -1 | 0.04 | 0.28 | -1.55 | -0.37 | -0.56 |
Gain (Loss) on Sale of Assets | 0.02 | - | -1.05 | 0.04 | 0.26 | - |
Asset Writedown | -0.69 | -0.17 | -1.86 | -3.83 | -6.27 | -1.74 |
Other Unusual Items | 0.72 | 0.96 | 5.4 | 5.58 | 6.36 | 5.21 |
Pretax Income | 17.36 | 17.63 | 82.21 | 218.74 | 105.8 | 124.99 |
Income Tax Expense | 1.77 | 2.21 | 10.46 | 27.58 | 12.99 | 17.59 |
Earnings From Continuing Operations | 15.59 | 15.41 | 71.76 | 191.16 | 92.81 | 107.4 |
Minority Interest in Earnings | 0.56 | 1.85 | -0.64 | -8.2 | -4.29 | -9.66 |
Net Income | 16.15 | 17.26 | 71.11 | 182.97 | 88.52 | 97.74 |
Net Income to Common | 16.15 | 17.26 | 71.11 | 182.97 | 88.52 | 97.74 |
Net Income Growth | -7.05% | -75.73% | -61.13% | 106.69% | -9.44% | 65.78% |
Shares Outstanding (Basic) | 114 | 108 | 108 | 99 | 81 | 81 |
Shares Outstanding (Diluted) | 114 | 108 | 108 | 99 | 81 | 81 |
Shares Change (YoY) | 9.67% | 0.11% | 8.95% | 21.78% | 0.54% | 0.02% |
EPS (Basic) | 0.14 | 0.16 | 0.66 | 1.85 | 1.09 | 1.21 |
EPS (Diluted) | 0.14 | 0.16 | 0.66 | 1.85 | 1.09 | 1.21 |
EPS Growth | -15.25% | -75.76% | -64.32% | 69.73% | -9.92% | 65.75% |
Free Cash Flow | -115.8 | -331.06 | -52.68 | -74.42 | 107.08 | -28.81 |
Free Cash Flow Per Share | -1.01 | -3.07 | -0.49 | -0.75 | 1.32 | -0.36 |
Dividend Per Share | 0.120 | 0.120 | 0.198 | 0.380 | 0.205 | - |
Dividend Growth | -39.39% | -39.39% | -47.89% | 85.37% | - | - |
Gross Margin | 10.23% | 9.78% | 18.36% | 24.15% | 21.55% | 28.62% |
Operating Margin | 1.32% | 0.26% | 8.53% | 16.62% | 13.60% | 19.32% |
Profit Margin | 2.27% | 2.73% | 10.74% | 17.57% | 10.63% | 14.38% |
Free Cash Flow Margin | -16.31% | -52.34% | -7.96% | -7.15% | 12.86% | -4.24% |
EBITDA | 46.92 | 35.97 | 86.51 | 203.77 | 135.14 | 151.24 |
EBITDA Margin | 6.61% | 5.69% | 13.07% | 19.57% | 16.22% | 22.25% |
D&A For EBITDA | 37.53 | 34.32 | 30.04 | 30.77 | 21.83 | 19.92 |
EBIT | 9.39 | 1.64 | 56.47 | 173 | 113.31 | 131.33 |
EBIT Margin | 1.32% | 0.26% | 8.53% | 16.62% | 13.60% | 19.32% |
Effective Tax Rate | 10.17% | 12.56% | 12.72% | 12.61% | 12.28% | 14.07% |
Revenue as Reported | 709.86 | 632.46 | 662.02 | 1,041 | 833.01 | 679.73 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.